Diversity and prevalence of antiretroviral genotypic resistance mutations among HIV-1-infected children

Almeida, Flávia J; Berezin, Eitan N; Rodrigues, Rosângela; Sáfadi, Marco A. P; Arnoni, Mariana V; Oliveira, Cristina; Brígido, Luis F. M.
J. pediatr. (Rio J.) ; 85(2): 104-109, mar.-abr. 2009. tab
Artigo em Português | LILACS | ID: lil-511346

Documentos relacionados

  1. Pre-treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China.
  2. Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe.
  3. Prevalence of HIV-1 Drug Resistance among Patients with Antiretroviral Therapy Failure in Sichuan, China, 2010-2016.
  4. Nano-RECall provides an integrated pipeline for HIV-1 drug resistance testing from Oxford Nanopore sequence data.
  5. Simultaneous prediction of multiple outcomes using revised stacking algorithms.
  6. HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon.
  7. Resistance rates among antiretroviral regimens in pregnant people living with HIV.
  8. Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey.
  9. Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study.
  10. Analysis of mutational history of multidrug-resistant genotypes with a mutagenetic tree model.